Researchers from the Department of Biomedical Research of the University of Bern and the University Clinic of Visceral Surgery and Medicine of the Inselspital Bern, Switzerland, have discovered that changes in the composition of the intestinal bacteria in patients with chronic inflammatory bowel disease affect the severity of the disease and the success of therapy. The advance provides an important basis to improve treatment of these diseases.
Enormous numbers of bacteria live in our intestines: they normally cause no disease and they are essential if we are to remain healthy.
If the delicate balance of these beneficial bacteria is disturbed through an unhealthy diet or side-effects of medications, the health-promoting functions of the bacteria are disrupted.
Without the right interactions between our bodies and our intestinal bacteria different sorts of disease are triggered, especially inflammatory bowel disease.
There are different forms of inflammatory bowel disease (IBD) – Crohn’s disease (which affects different segments of the entire intestinal tract) and ulcerative colitis (which affects the large intestine). These conditions affect about 30 people per 100,000 of the European and North American populations.
Over the last 10 years the incidence of IBD in Switzerland has sharply increased: in 2004 there were about 12,000 patients compared with 20,000 in 2014.
Since IBD usually starts before the age of 35, with major ongoing limitations for the quality of life and ability to work, the conditions also have severe social and economic consequences.
New results have now been reported on the relationships of intestinal bacteria in IBD patients by the research team led by Andrew Macpherson, Bahtiyar Yilmaz und Pascal Juillerat in the Department of Biomedical Research in the University of Bern and the University Clinic of Visceral Surgery and Medicine of the Inselspital.
They have discovered that changes of particular species of intestinal bacteria lead to severe relapsing disease resistant to therapy and even make the return of the disease more likely in patients whose active segments of Crohn’s disease have been surgically removed. The work is being published in the journal ‘Nature Medicine’.
Networks of intestinal bacteria
The researchers examined the relationship between the intestinal microbes, the way in which the disease developed, and how it responded to treatment in 270 patients with Crohn’s disease, 232 patients with ulcerative colitis and 227 healthy individuals.
The intestinal samples were provided from two large patient cohorts, the Swiss IBD cohort (www.ibdcohort.ch) led by Professor Gerhard Rogler of the University Hospital of Zürich, with major contributions from many different Swiss hospitals and Gastroenterology community practices, and a separate cohort of patients from the Gastroenterologists of the Inselspital Bern.
Dr. Bahtiyar Yilmaz, the co-first author of the study commented, ‘The availability of this range of material from two separate groups of patients studied over many years with unprecedented documentation of all the clinical details by Swiss gastroenterologists and the staff of the Inselspital Bern made our study unique’.
The analysis of the intestinal samples showed that the microbes in IBD patients differ significantly from those of healthy individuals. This is mainly caused by increases of some species of bacteria that can trigger or worsen the disease, and reductions in bacterial species that are important for maintaining health in the intestine.
The researchers found 18 new sorts of bacteria that could affect the disease outcome. They were also able to show that body habitus, age, lifestyle and the type of treatment had a major effect on these intestinal microbes. Professor Andrew Macpherson, leader of the study and last author commented, ‘We found that the different bacterial groups were living associated together in distinct communities, and it is the disruption of these community networks between the different bacterial species affect the disease. Like the communities in human society, every individual bacterial species has its place in the community if the intestine is to remain healthy. One of these bacterial communities is especially important, because its different bacterial members produce short chain fatty acids, which feed the epithelial cells that line the surface of intestinal tissues and help them to build a tight barrier between the contents of the gut and the underlying tissues of the body.’
Computational methods are essential to interpret the results
Mathematical algorithms were used to process the results in the search within thousands of different sorts of bacteria, to find those networks of beneficial bacterial species that are important to avoid severe disease and to make the case likely to respond to therapy. Andrew Macpherson commented, ‘Patients with Crohn’s disease and ulcerative colitis have huge differences in the severity of the clinical course and responsiveness to treatment – this makes it difficult for doctors to decide which particular therapy is like to be successful.
Sadly, at present, there are a few patients in whom almost all therapies do not work well. We hope to use these results to improve the outcome, especially for the most severely affected patients.’
Pascal Juillerat, co-first author of the study, commented, ‘Since we now know the specific microbial signatures and how the networks of beneficial and damaging bacteria are built up, we should be able to manipulate the intestinal bacteria in a designed way – specific for individual patients – as a way of settling their disease. Since every person has a different composition of their intestinal microbiota, we will need to do this on an individual basis.’
Last, but not least, the relapsing-remitting nature of IBD has huge costs for the quality of life and places a burden not only on the patients and their families, but also on the very substantial costs for Swiss Healthcare. The researchers hope that this new approach can provide a new way to help those affected and to reduce the financial burden for the Swiss community.
The Swiss IBD cohort study was financed by the Swiss National Foundation for Research and the GutX-program of the research initiative for systems biology (medical program) SystemsX. The SystemsX computational biology section of the study was led by Prof. Jörg Stelling, ETH Zürich.
Dr. Bahtiyar Yilmaz
Department for Biomedical Research, University of Bern, and University Clinic of Visceral Surgery and Medicine of the University Hospital, Inselspital
Phone +41 31 632 86 82 / firstname.lastname@example.org
Bahtiyar Yilmaz, Pascal Juillerat, Ove Øyås, Charlotte Ramon, Francisco Damian Bravo, Yannick Franc, Nicolas Fournier, Pierre Michetti, Christoph Mueller, Markus Geuking, Valerie E. H. Pittet, Michel H. Maillard, Gerhard Rogler, Swiss IBD Cohort Investigators, Reiner Wiest, Jörg Stelling and Andrew J. Macpherson: Microbial network disturbances in relapsing refractory Crohn’s disease, Nature Medicine, 21 January 2019, http://dx.doi.org/10.1038/s41591-018-0308-z
Nathalie Matter | Universität Bern
First SARS-CoV-2 genomes in Austria openly available
03.04.2020 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften
Do urban fish exhibit impaired sleep? Light pollution suppresses melatonin production in European perch
03.04.2020 | Leibniz-Institut für Gewässerökologie und Binnenfischerei (IGB)
Drops of water falling on or sliding over surfaces may leave behind traces of electrical charge, causing the drops to charge themselves. Scientists at the Max Planck Institute for Polymer Research (MPI-P) in Mainz have now begun a detailed investigation into this phenomenon that accompanies us in every-day life. They developed a method to quantify the charge generation and additionally created a theoretical model to aid understanding. According to the scientists, the observed effect could be a source of generated power and an important building block for understanding frictional electricity.
Water drops sliding over non-conducting surfaces can be found everywhere in our lives: From the dripping of a coffee machine, to a rinse in the shower, to an...
90 million-year-old forest soil provides unexpected evidence for exceptionally warm climate near the South Pole in the Cretaceous
An international team of researchers led by geoscientists from the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) have now...
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply. When the iron transport into the bacteria is inhibited, the pathogen can no longer grow. This opens novel ways to develop targeted tuberculosis drugs.
One of the most devastating pathogens that lives inside human cells is Mycobacterium tuberculosis, the bacillus that causes tuberculosis. According to the...
An international team with the participation of Prof. Dr. Michael Kues from the Cluster of Excellence PhoenixD at Leibniz University Hannover has developed a new method for generating quantum-entangled photons in a spectral range of light that was previously inaccessible. The discovery can make the encryption of satellite-based communications much more secure in the future.
A 15-member research team from the UK, Germany and Japan has developed a new method for generating and detecting quantum-entangled photons at a wavelength of...
Together with their colleagues from the University of Würzburg, physicists from the group of Professor Alexander Szameit at the University of Rostock have devised a “funnel” for photons. Their discovery was recently published in the renowned journal Science and holds great promise for novel ultra-sensitive detectors as well as innovative applications in telecommunications and information processing.
The quantum-optical properties of light and its interaction with matter has fascinated the Rostock professor Alexander Szameit since College.
02.04.2020 | Event News
26.03.2020 | Event News
23.03.2020 | Event News
03.04.2020 | Materials Sciences
03.04.2020 | Life Sciences
03.04.2020 | Life Sciences